Oral and pharyngeal mucosal surface

The oral and pharyngeal mucosal surface is the stratified squamous epithelial lining of the oral cavity and pharynx, serving as the primary interface between the external environment and the upper gastrointestinal and respiratory tracts (StatPearls, 2023). It functions as a protective barrier against mechanical abrasion, chemical irritants, and pathogens, while also hosting minor salivary glands for lubrication and specialized sensory receptors for taste and touch (NIH, 2024). While not a single molecular target, this tissue is a critical site for drug administration, where medications like lidocaine or chlorhexidine are applied topically to treat local inflammation, infections, or pain (PubChem, 2024). Pathologically, it is the site of origin for oropharyngeal squamous cell carcinomas and is frequently affected by treatment-induced toxicities such as oral mucositis following chemotherapy or radiation (National Cancer Institute, 2024). The surface's permeability is a key factor in the pharmacokinetics of transmucosal drug delivery, allowing for rapid systemic entry of certain small molecules while excluding larger or more polar compounds (Journal of Controlled Release, 2022). Understanding the cellular turnover and immune environment of this surface is essential for developing targeted therapies for chronic inflammatory conditions and early detection of malignant transformations.

Other names

Oral mucosaPharyngeal mucosaOropharyngeal mucosaMouth liningOral mucous membrane

Drugs applied to this surface typically act via topical absorption to reach underlying nerve endings (anesthetics), provide local antimicrobial activity (antiseptics/antifungals), or modulate local inflammatory responses through glucocorticoid receptor activation (corticosteroids).